ALT earnings: a positive outcome, +7.0%

On May 11, 2023, Altimmune, Inc. reached its earnings. The result was a positive outcome, and the stock moved +7.0% in the window around the event. It had already run +18.8% in the 30 days into the catalyst — the kind of pre-event run-up that often precedes binary readouts.